date,title,source
Oct-22-18,Protagonist Therapeutics Presents Clinical Data from the PROPEL Study of PTG-100 in Ulcerative Colitis at United European Gastroenterology Week,PR Newswire
Oct-29-18,Protagonist Therapeutics (PTGX) Q3 Earnings Preview: What to Know Ahead of the Release,Zacks
Nov-06-18,"Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-06-18,Protagonist Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Protagonist Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,PR Newswire
Nov-06-18,Protagonist Therapeutics Announces Completion of Phase 1 Clinical Trial of Oral IL-23 Receptor Antagonist PTG-200,PR Newswire
Nov-07-18,"Protagonist Therapeutics to Present at the Stifel 2018 Healthcare Conference Wednesday, Nov. 14",PR Newswire
Nov-09-18,"New Research Coverage Highlights American Public Education, Protagonist Therapeutics, TravelCenters of America, Five Prime Therapeutics, Red Robin Gourmet Burgers, and Hemisphere Media Group  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-27-18,Protagonist Therapeutics Announces New Development Candidate PN-10943 for the Treatment of Inflammatory Bowel Disease,PR Newswire
Nov-29-18,"The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved",Benzinga
Dec-13-18,"Protagonist Therapeutics Initiates Phase 1 Trial of Oral, Gut-Restricted, Alpha-4-Beta-7 Integrin Antagonist PN-10943",PR Newswire
Dec-20-18,"Who Has Been Buying Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Shares?",Simply Wall St.
Dec-24-18,"Health Care Digest: 'Killing off' the JPM Week golden goose, a $75 million complement and more",American City Business Journals
Jan-09-19,Protagonist Therapeutics Initiates Phase 2 Trial of Novel Hepcidin Mimetic PTG-300 for the Treatment of Patients with Beta Thalassemia,PR Newswire
Jan-16-19,Protagonist Therapeutics Reports Granting of Inducement Award,PR Newswire
Feb-05-19,"Investor Expectations to Drive Momentum within Continental Resources, Protagonist Therapeutics, Mobile Mini, J & J Snack Foods, Griffon, and Nordson  Discovering Underlying Factors of Influence",GlobeNewswire
Feb-21-19,"Protagonist Therapeutics to Present at the Leerink Partners 8th Annual Global Healthcare Conference on Thursday, Feb. 28",PR Newswire
Mar-05-19,Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results,PR Newswire
Mar-12-19,Protagonist Therapeutics: 4Q Earnings Snapshot,Associated Press
Mar-12-19,Protagonist Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results,PR Newswire
